{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:50:29Z","timestamp":1791219029028,"version":"4.1.0"},"reference-count":233,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009193","name":"Marsden Fund","doi-asserted-by":"publisher","award":["UOO1004"],"award-info":[{"award-number":["UOO1004"]}],"id":[{"id":"10.13039\/501100009193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["16\/232"],"award-info":[{"award-number":["16\/232"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["NZ 13\/263"],"award-info":[{"award-number":["NZ 13\/263"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbapap.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:42:29Z","timestamp":1551872549000},"page":"140206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Fungal Lanosterol 14\u03b1-demethylase: A target for next-generation antifungal design"],"prefix":"10.1016","volume":"1868","author":[{"given":"Brian C.","family":"Monk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia A.","family":"Sagatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen N.","family":"Ruma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni K.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Keniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2019.02.008_bb0005","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0052-2016","article-title":"Fungal diversity revisited: 2.2 to 3.8 million species","volume":"5","author":"Hawksworth","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0010","series-title":"The Fungal Kingdom","year":"2018"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature10947","article-title":"Emerging fungal threats to animal, plant and ecosystem health","volume":"484","author":"Fisher","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0027-2016","article-title":"Emerging fungal threats to plants and animals challenge agriculture and ecosystem resilience","volume":"5","author":"Fones","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0025","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0030","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.1324245111","article-title":"Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer","volume":"111","author":"Monk","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0035","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1073\/pnas.74.11.4924","article-title":"Differential effects of cholesterol and lanosterol on artificial membranes","volume":"74","author":"Yeagle","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ddr.430080133","article-title":"Cytochrome P450: target for intraconazole","volume":"8","author":"Vanden Bossche","year":"1986","journal-title":"Drug Devel Res"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0045","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M115.677310","article-title":"Structure-functional characterization of cytochrome P450 sterol 14alpha-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs","volume":"290","author":"Hargrove","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0050","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14alpha-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0055","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00570-17","article-title":"Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14alpha-demethylase provides insights into its broad-spectrum antifungal activity","volume":"61","author":"Hargrove","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0065","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1128\/AAC.00925-15","article-title":"Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14alpha-demethylase","volume":"59","author":"Sagatova","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/mmy\/myx144","article-title":"I.E.A.R.S.w. group, Triazole resistance surveillance in Aspergillus fumigatus","volume":"56","author":"Resendiz Sharpe","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0080","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0085","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0090","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/AAC.00747-06","article-title":"Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae","volume":"50","author":"Chau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0021859605004971","article-title":"A century of fungicide evolution","volume":"143","author":"Russell","year":"2005","journal-title":"J Agricultural Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0100","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype-phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fgb.2011.08.002","article-title":"The structure-function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance","volume":"48","author":"Snelders","year":"2011","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1094\/PDIS-05-15-0574-FE","article-title":"Toward a reduced reliance on conventional pesticides in European agriculture","volume":"100","author":"Lamichhane","year":"2016","journal-title":"Plant Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.bbapap.2019.02.008_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-018-1152-2","article-title":"Neuroinfections caused by fungi","author":"Goralska","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0145","article-title":"Present and future therapy of Cryptococcus infections","volume":"4","author":"Mourad","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijantimicag.2017.05.012","article-title":"Molecular basis of antifungal drug resistance in yeasts","volume":"50","author":"Morio","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0155","first-page":"2173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida Species","volume":"7","author":"Whaley","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00253-012-4195-9","article-title":"Fungal cytochrome P450 sterol 14alpha-demethylase (CYP51) and azole resistance in plant and human pathogens","volume":"95","author":"Becher","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0170","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0175","article-title":"The impact of homologous resistance mutations from pathogenic yeast on Saccharomyces cerevisiae lanosterol 14alpha-demethylase","author":"Sagatova","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/srep26213","article-title":"Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14alpha-demethylase","volume":"6","author":"Sagatova","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1159746","article-title":"Outwitting multidrug resistance to antifungals","volume":"321","author":"Monk","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/fow020","article-title":"Ploidy plasticity: a rapid and reversible strategy for adaptation to stress","volume":"16","author":"Berman","year":"2016","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0195","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0200","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0205","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of Candida albicans","volume":"4","author":"Ford","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0215","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1006\/bbrc.1995.1272","article-title":"Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol","volume":"207","author":"Kelly","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0220","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0225","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/EC.00245-13","article-title":"Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence","volume":"13","author":"Lohberger","year":"2014","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12275-016-5628-4","article-title":"The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen","volume":"54","author":"Morschhauser","year":"2016","journal-title":"J Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschhauser","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0245","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkm321","article-title":"The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum","volume":"60","author":"Nakayama","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0250","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/EC.00345-12","article-title":"Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae","volume":"12","author":"Zavrel","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fphys.2014.00143","article-title":"Multidrug resistance in fungi: regulation of transporter-encoding gene expression","volume":"5","author":"Paul","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0260","first-page":"1119","article-title":"Environmental azole fungicide, prochloraz, can induce cross-resistance to medical triazoles in Candida glabrata","volume":"14","author":"Faria-Ramos","year":"2014","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0265","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3389\/fmicb.2016.02038","article-title":"Fluconazole and echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a french cohort of patients harboring low rates of resistance","volume":"7","author":"Delliere","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","author":"Healey","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0275","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0280","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1128\/AAC.01358-15","article-title":"Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis","volume":"59","author":"Berkow","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"G. Global Antifungal Surveillance, Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0290","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/AAC.02603-14","article-title":"In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei","volume":"58","author":"Ricardo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0295","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11046-014-9831-8","article-title":"The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia","volume":"179","author":"Tan","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clinmicnews.2017.06.003","article-title":"Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species","volume":"39","author":"Lockhart","year":"2017","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2017.08.017","article-title":"Candida auris: An emerging multidrug-resistant pathogen","volume":"63","author":"Sears","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0315","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0320","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0325","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/cid\/cix867","article-title":"Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated Cryptococcosis: A population-based study","volume":"66","author":"George","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0330","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","article-title":"Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment","volume":"57","author":"Sionov","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0335","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","article-title":"The investigational drug VT-1129 Is a highly potent inhibitor of Cryptococcus species CYP51 but only weakly inhibits the human enzyme","volume":"60","author":"Warrilow","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0340","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/nature04220","article-title":"Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak","volume":"437","author":"Fraser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0345","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/JCM.01190-13","article-title":"Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility","volume":"51","author":"Datta","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0350","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0355","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkn132","article-title":"MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii","volume":"62","author":"Torres-Rodriguez","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16123-9","article-title":"Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14alpha-demethylase","volume":"7","author":"Caramalho","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0365","doi-asserted-by":"crossref","first-page":"e02280","DOI":"10.1128\/AAC.02280-16","article-title":"In vitro and in vivo antifungal profile of a novel and long-acting inhaled azole, PC945, on Aspergillus fumigatus infection","volume":"61","author":"Colley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0370","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/JCM.39.7.2431-2438.2001","article-title":"Identification of two different 14-\u03b1 sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species","volume":"39","author":"Mellado","year":"2001","journal-title":"J Clinical Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0375","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Applied Envir Microbiology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0380","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mib.2005.06.017","article-title":"Aspergillus fumigatus: saprophyte or pathogen?","volume":"8","author":"Tekaia","year":"2005","journal-title":"Curr Opinion Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Diseases"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0390","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-7022-1-4","article-title":"Impact of Aspergillus fumigatus in allergic airway diseases","volume":"1","author":"Chaudhary","year":"2011","journal-title":"Clin and Translational Allergy"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0395","doi-asserted-by":"crossref","first-page":"s346","DOI":"10.2741\/1002","article-title":"Ecology and taxonomy of pathogenic aspergilli","volume":"8","author":"Gugnani","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0400","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1128\/AEM.68.8.3886-3890.2002","article-title":"Occurrence of toxigenic Aspergillus versicolor isolates and sterigmatocystin in carpet dust from damp indoor environments","volume":"68","author":"Engelhart","year":"2002","journal-title":"Applied Envir Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0405","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2222.1993.tb00330.x","article-title":"Environmental exposure to Aspergillus fumigatus allergen (Asp f I)","volume":"23","author":"Sporik","year":"1993","journal-title":"Clinical Experimental Allergy"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0410","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"J Allergy Clin Immunology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0415","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0420","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0425","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1080\/13693780600826715","article-title":"Treatment of invasive aspergillosis: Polyenes, echinocandins, or azoles?","volume":"44","author":"Patterson","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0430","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0435","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1080\/13693780600826715","article-title":"Treatment of invasive aspergillosis: Polyenes, echinocandins, or azoles?","volume":"44","author":"Patterson","year":"2006","journal-title":"Medical Mycology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0440","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"New England J Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0445","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11908-011-0216-6","article-title":"Current role of echinocandins in the management of invasive aspergillosis","volume":"13","author":"Mikulska","year":"2011","journal-title":"Curr Infect Dis Reports"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0450","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0455","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype\u2013phenotype complexity of the TR 46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genetics and Biology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0460","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.05027-11","article-title":"SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A)","volume":"56","author":"Blosser","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0465","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/AAC.00316-10","article-title":"Expression, purification, and characterization of Aspergillus fumigatus sterol 14-\u03b1 demethylase (CYP51) isoenzymes A and B","volume":"54","author":"Warrilow","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0470","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0475","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"Van Der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0480","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.foreco.2016.09.032","article-title":"Drivers of emerging fungal diseases of forest trees","volume":"381","author":"Ghelardini","year":"2016","journal-title":"Forest Ecol Manag"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0485","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Hallen-Adams","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0490","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1210\/en.2014-1561","article-title":"Mechanism of inhibition of estrogen biosynthesis by azole fungicides","volume":"155","author":"Egbuta","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0495","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ppa.12128","article-title":"Constraints on the evolution of azole resistance in plant pathogenic fungi","volume":"62","author":"Cools","year":"2013","journal-title":"Plant Pathology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0500","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpls.2015.00102","article-title":"Recent advances in the Zymoseptoria tritici\u2013wheat interaction: insights from pathogenomics","volume":"6","author":"McDonald","year":"2015","journal-title":"Frontiers Plant Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0505","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1128\/AEM.00027-11","article-title":"Impact of recently emerged sterol 14{alpha}-demethylase (CYP51) variants of Mycosphaerella graminicola on azole fungicide sensitivity","volume":"77","author":"Cools","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0510","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1128\/AEM.03965-14","article-title":"Novel substrate specificity and temperature-sensitive activity of Mycosphaerella graminicola CYP51 supported by the native NADPH cytochrome P450 reductase","volume":"81","author":"Price","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0515","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1590\/S1415-47572008005000026","article-title":"Evolutionary history of Phakopsora pachyrhizi (the Asian soybean rust) in Brazil based on nucleotide sequences of the internal transcribed spacer region of the nuclear ribosomal DNA","volume":"31","author":"Freire","year":"2008","journal-title":"Genet Molec Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0520","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1094\/PD-89-0675","article-title":"Epidemics of soybean rust (Phakopsora pachyrhizi) in Brazil and Paraguay from 2001 to 2003","volume":"89","author":"Yorinori","year":"2005","journal-title":"Plant Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0525","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ps.3562","article-title":"Sensitivity of Phakopsora pachyrhizi towards quinone-outside-inhibitors and demethylation-inhibitors, and corresponding resistance mechanisms","volume":"70","author":"Schmitz","year":"2014","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0530","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12154-014-0121-1","article-title":"Resistance to antifungals that target CYP51","volume":"7","author":"Parker","year":"2014","journal-title":"J Chem Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0535","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.4134","article-title":"Inhibition of CBLB protects from lethal Candida albicans sepsis","volume":"22","author":"Wirnsberger","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0540","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1534\/genetics.114.161620","article-title":"The yeast deletion collection: a decade of functional genomics","volume":"197","author":"Giaever","year":"2014","journal-title":"Genetics"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0545","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/6791","article-title":"Genomic profiling of drug sensitivities via induced haploinsufficiency","volume":"21","author":"Giaever","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0550","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/EC.00091-07","article-title":"Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae","volume":"6","author":"Lamping","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0555","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.dld.2017.08.025","article-title":"The mycobiome: Role in health and disease, and as a potential probiotic target in gastrointestinal disease","volume":"49","author":"Hager","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0560","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ps.1568","article-title":"Are azole fungicides losing ground against Septoria wheat disease? Resistance mechanisms in Mycosphaerella graminicola","volume":"64","author":"Cools","year":"2008","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0565","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0570","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/molecules15064129","article-title":"Conazoles","volume":"15","author":"Heeres","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0575","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-2952(87)90694-0","article-title":"Interaction of azole antifungal agents with cytochrome P450 14DM purified from Saccharomyces cerevisiae microsomes","volume":"36","author":"Yoshida","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0580","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0006-291X(82)91129-9","article-title":"A requirement for ergosterol to permit growth of yeast sterol auxotrophs on cholestanol","volume":"106","author":"Rodriguez","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0585","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0006-291X(89)91792-0","article-title":"Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals","volume":"164","author":"Watson","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","article-title":"Overview of medically important antifungal azole derivatives","volume":"1","author":"Fromtling","year":"1988","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.bbapap.2019.02.008_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","article-title":"History of the development of azole derivatives","volume":"10","author":"Maertens","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0600","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/iai.4.2.143-148.1971","article-title":"In vitro antifungal activity of clotrimazole (Bay b 5097)","volume":"4","author":"Shadomy","year":"1971","journal-title":"Infect Immun"},{"issue":"Suppl. 1","key":"10.1016\/j.bbapap.2019.02.008_bb0605","first-page":"17","article-title":"Toxicity of clotrimazole","volume":"50","author":"Tettenborn","year":"1974","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0610","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-198019010-00002","article-title":"Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections","volume":"19","author":"Heel","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0615","doi-asserted-by":"crossref","first-page":"432","DOI":"10.7326\/0003-4819-93-3-432","article-title":"Cardiorespiratory toxicity due to miconazole","volume":"93","author":"Fainstein","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0620","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0625","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/bpb.28.1805","article-title":"Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes","volume":"28","author":"Niwa","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0630","first-page":"605","article-title":"Ketoconazole associated hepatotoxicity: a systematic review and meta- analysis","volume":"26","author":"Yan","year":"2013","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0635","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14740338.2015.983071","article-title":"Drug safety assessment of oral formulations of ketoconazole","volume":"14","author":"Gupta","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0640","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0645","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1073\/pnas.0603236103","article-title":"Structural basis for ligand promiscuity in cytochrome P450 3A4","volume":"103","author":"Ekroos","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0650","article-title":"Revisiting the metabolism and bioactivation of ketoconazole in human and mouse using liquid chromatography-mass spectrometry-based metabolomics","volume":"18","author":"Kim","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0655","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0660","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/dmd.31.5.540","article-title":"Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole","volume":"31","author":"Hyland","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0665","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0670","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mmcr.2017.11.004","article-title":"Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis","volume":"19","author":"Mpoza","year":"2018","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0675","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0680","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: Consistency with results from clinical trials","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0685","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0690","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0695","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajog.2017.08.084","article-title":"Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis","volume":"217","author":"Sobel","year":"2017","journal-title":"Am J Obstetrics Gynecology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0700","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/AAC.02770-15","article-title":"The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against Cryptococcus neoformans and Cryptococcus gattii","volume":"60","author":"Lockhart","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0705","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jac\/dkx410","article-title":"Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0710","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/ps.4029","article-title":"Azole fungicides - understanding resistance mechanisms in agricultural fungal pathogens","volume":"71","author":"Price","year":"2015","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0715","series-title":"Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species","author":"Kleinkauf","year":"2013"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0720","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/AEM.03246-12","article-title":"Prothioconazole and prothioconazole-desthio activities against Candida albicans sterol 14-alpha-demethylase","volume":"79","author":"Parker","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167485","article-title":"Structural and functional elucidation of yeast lanosterol 14alpha-demethylase in complex with agrochemical antifungals","volume":"11","author":"Tyndall","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0730","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171290","article-title":"Recombinant production of eukaryotic cytochrome P450s in microbial cell factories","volume":"38","author":"Hausjell","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0735","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbrc.2013.07.057","article-title":"High-level heterologous expression of fungal cytochrome P450s in Escherichia coli","volume":"438","author":"Ichinose","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0740","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0745","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/AAC.00316-10","article-title":"Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B","volume":"54","author":"Warrilow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0750","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1021\/cr5003134","article-title":"Drug strategies targeting CYP51 in neglected tropical diseases","volume":"114","author":"Choi","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001736","article-title":"Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51","volume":"6","author":"Gunatilleke","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0760","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/jm801643b","article-title":"Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase","volume":"52","author":"Konkle","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0765","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijfoodmicro.2009.01.035","article-title":"Effects of temperature, pH and sugar concentration on the growth parameters of Saccharomyces cerevisiae, S. kudriavzevii and their interspecific hybrid","volume":"131","author":"Arroyo-Lopez","year":"2009","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0770","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/AEM.01861-10","article-title":"Temperature adaptation markedly determines evolution within the genus Saccharomyces","volume":"77","author":"Salvado","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0775","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1567-1364.12035","article-title":"Heterologous expression of Candida albicans Pma1p in Saccharomyces cerevisiae","volume":"13","author":"Keniya","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0780","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2958.2012.08140.x","article-title":"Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor","volume":"85","author":"Niimi","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0785","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.49.1.57-70.2005","article-title":"Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance","volume":"49","author":"Monk","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126350","article-title":"Inhibitors of the Candida albicans Major Facilitator Superfamily transporter Mdr1p responsible for fluconazole resistance","volume":"10","author":"Keniya","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0795","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1534\/genetics.117.300554","article-title":"A novel sterol-signaling pathway governs azole antifungal drug resistance and hypoxic gene repression in Saccharomyces cerevisiae","volume":"208","author":"Serratore","year":"2018","journal-title":"Genetics"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0800","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.00555-13","article-title":"Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals","volume":"57","author":"Eddouzi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0805","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0810","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1128\/AAC.00587-10","article-title":"Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51)","volume":"54","author":"Warrilow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0815","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pep.2007.06.007","article-title":"Improved cloning and expression of cytochrome P450s and cytochrome P450 reductase in yeast","volume":"56","author":"Hamann","year":"2007","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0820","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/abbi.2000.1864","article-title":"Functional expression of regiospecific cytochrome P450 limonene hydroxylases from mint (Mentha spp.) in Escherichia coli and Saccharomyces cerevisiae","volume":"379","author":"Haudenschild","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0825","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbrc.2010.07.094","article-title":"Genome-to-function characterization of novel fungal P450 monooxygenases oxidizing polycyclic aromatic hydrocarbons (PAHs)","volume":"399","author":"Syed","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0830","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/cbic.200500200","article-title":"Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris","volume":"6","author":"Dietrich","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0835","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jbiotec.2007.02.003","article-title":"Functional expression and characterisation of human cytochrome P45017alpha in Pichia pastoris","volume":"129","author":"Kolar","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0840","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/mmy\/myw023","article-title":"The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance","volume":"54","author":"Alvarez-Rueda","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0845","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fmicb.2015.00457","article-title":"Heterologous expression of the Monilinia fructicola CYP51 (MfCYP51) gene in Pichia pastoris confirms the mode of action of the novel fungicide, SYP-Z048","volume":"6","author":"Chen","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0850","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2010.06.006","article-title":"Structural basis for conservation in the CYP51 family","volume":"1814","author":"Lepesheva","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0855","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/pathogens3030549","article-title":"Host pathogen relations: exploring animal models for fungal pathogens","volume":"3","author":"Harwood","year":"2014","journal-title":"Pathogens"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0860","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00240-18","article-title":"A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis","volume":"62","author":"Poelmans","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0865","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-018-0013-2","article-title":"ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection","volume":"10","author":"Zhou","year":"2018","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0870","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02576-17","article-title":"Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis","author":"Savage","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0875","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jgar.2018.04.012","article-title":"In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and resistant isolates of Candida albicans","volume":"14","author":"Sa","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0880","article-title":"Cross-Linked fluorescent supramolecular nanoparticles for intradermal controlled release of antifungal drug - A therapeutic approach for onychomycosis","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0885","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41590-018-0084-4","article-title":"Of mice, men and immunity: a case for evolutionary systems biology","volume":"19","author":"Ernst","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0890","article-title":"Creation of \"humanized\" mice to study human immunity","volume":"15","author":"Pearson","year":"2008","journal-title":"Curr Protoc Immunol, Chapter"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0895","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00335-017-9703-x","article-title":"Modeling human disease in rodents by CRISPR\/Cas9 genome editing","volume":"28","author":"Birling","year":"2017","journal-title":"Mamm Genome"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0900","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2958.2006.05357.x","article-title":"Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2","volume":"62","author":"Holmes","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0905","doi-asserted-by":"crossref","first-page":"15675","DOI":"10.1073\/pnas.232568599","article-title":"Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis","volume":"99","author":"Mylonakis","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0910","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-61779-539-8_31","article-title":"Caenorhabditis elegans: a nematode infection model for pathogenic fungi","volume":"845","author":"Muhammed","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0915","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vetmic.2016.07.022","article-title":"Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans","volume":"192","author":"Brilhante","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0920","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1099\/mic.0.000222","article-title":"Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans\/Cryptococcus gattii species complex","volume":"162","author":"Cordeiro Rde","year":"2016","journal-title":"Microbiology"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0925","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00701-17","article-title":"Reversal of azole resistance in Candida albicans by sulfa antibacterial drugs","volume":"62","author":"Eldesouky","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0930","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.phymed.2017.12.033","article-title":"Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans","volume":"40","author":"Sun","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13100993","article-title":"The Use of the nematode Caenorhabditis elegans to evaluate the adverse effects of epoxiconazole exposure on spermatogenesis","volume":"13","author":"Li","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0940","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.72.10.4061","article-title":"Normal and mutant thermotaxis in the nematode Caenorhabditis elegans","volume":"72","author":"Hedgecock","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0945","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4161\/viru.21972","article-title":"Effect of nutrient deprivation on the susceptibility of Galleria mellonella larvae to infection","volume":"3","author":"Banville","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0950","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.funbio.2015.06.002","article-title":"Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species","volume":"120","author":"Binder","year":"2016","journal-title":"Fungal Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0955","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/viru.1.6.12985","article-title":"Methods for using Galleria mellonella as a model host to study fungal pathogenesis","volume":"1","author":"Fuchs","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0960","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00189-16","article-title":"Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species","volume":"1","author":"Borman","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0965","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41426-018-0095-0","article-title":"The first isolate of Candida auris in China: clinical and biological aspects","volume":"7","author":"Wang","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0970","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1080\/21505594.2017.1347744","article-title":"Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy","volume":"8","author":"Ames","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0975","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/mmy\/myx124","article-title":"Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata","volume":"56","author":"Bordallo-Cardona","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0980","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fmicb.2016.01309","article-title":"Antifungal effect of novel 2-Bromo-2-Chloro-2-(4-Chlorophenylsulfonyl)-1-Phenylethanone against Candida Strains","volume":"7","author":"Staniszewska","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0985","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1574-695X.2002.tb00617.x","article-title":"Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae","volume":"34","author":"Brennan","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0990","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/IAI.73.7.4161-4170.2005","article-title":"Superoxide production in Galleria mellonella hemocytes: identification of proteins homologous to the NADPH oxidase complex of human neutrophils","volume":"73","author":"Bergin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.bbapap.2019.02.008_bb0995","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/21505594.2017.1370174","article-title":"Analysis of the early cellular and humoral responses of Galleria mellonella larvae to infection by Candida albicans","volume":"9","author":"Sheehan","year":"2018","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1000","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/21505594.2015.1081330","article-title":"Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model","volume":"6","author":"Delarze","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jgar.2017.11.011","article-title":"In vivo activity of fluconazole\/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection","volume":"13","author":"Gu","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00895-17","article-title":"Fluconazole pharmacokinetics in Galleria mellonella larvae and performance evaluation of a bioassay compared to liquid chromatography-tandem mass spectrometry for hemolymph specimens","volume":"61","author":"Astvad","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1015","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1248\/bpb.b13-00270","article-title":"Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents","volume":"36","author":"Li","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00241-18","article-title":"Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms","volume":"62","author":"Garcia-Rubio","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01659-17","article-title":"Identification and characterization of key charged residues in the cofilin protein involved in azole susceptibility, apoptosis, and virulence of Aspergillus fumigatus","volume":"62","author":"Lu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fgb.2018.02.003","article-title":"In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis","volume":"113","author":"Ballard","year":"2018","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1035","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060047","article-title":"Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile","volume":"8","author":"Scorzoni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1515\/pjvs-2015-0086","article-title":"Zebrafish: an animal model for research in veterinary medicine","volume":"18","author":"Nowik","year":"2015","journal-title":"Pol J Vet Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1050","first-page":"811","article-title":"A rapid and effective method for screening, sequencing and reporter verification of engineered frameshift mutations in zebrafish","volume":"10","author":"Prykhozhij","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/626745","article-title":"Experimental models of cryptococcosis","author":"Sabiiti","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fmicb.2018.00387","article-title":"The intestinal mycobiota in wild zebrafish comprises mainly Dothideomycetes while Saccharomycetes predominate in their Laboratory-reared counterparts","volume":"9","author":"Siriyappagouder","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bmc.2016.01.058","article-title":"Synthesis and evaluation of thiophene-based guanylhydrazones (iminoguanidines) efficient against panel of voriconazole-resistant fungal isolates","volume":"24","author":"Ajdacic","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1070","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.chemosphere.2017.09.027","article-title":"Single and mixture toxicity of abamectin and difenoconazole to adult zebrafish (Danio rerio)","volume":"188","author":"Sanches","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-35072-1_5","article-title":"Membrane Protein Crystallisation: Current Trends and Future Perspectives","volume":"922","author":"Parker","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1080","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.1324245111","article-title":"Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer","volume":"111","author":"Monk","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.42.2.241","article-title":"Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents","volume":"42","author":"Sanglard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1090","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ps.2028","article-title":"Multiple mechanisms account for resistance to sterol 14alpha-demethylation inhibitors in field isolates of Mycosphaerella graminicola","volume":"67","author":"Leroux","year":"2011","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1100","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/aem.63.8.2966-2970.1997","article-title":"A mutation in the 14 alpha-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor","volume":"63","author":"Delye","year":"1997","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ps.1770","article-title":"Analysis of the CYP51 gene and encoded protein in propiconazole-resistant isolates of Mycosphaerella fijiensis","volume":"65","author":"Canas-Gutierrez","year":"2009","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1110","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1115","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1120","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1371\/journal.pntd.0000651","article-title":"Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole","volume":"4","author":"Chen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00390-17","article-title":"Prophylactic treatment with VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","author":"Gebremariam","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1130","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","volume":"59","author":"Gebremariam","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1135","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01941-17","article-title":"In Vitro and In Vivo efficacy of a novel and long-acting fungicidal azole, PC1244, on Aspergillus fumigatus infection","volume":"62","author":"Colley","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1145","author":"Friggeri","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139306","article-title":"Changes in the sterol composition of the plasma membrane affect membrane potential, salt tolerance and the activity of multidrug resistance pumps in Saccharomyces cerevisiae","volume":"10","author":"Kodedova","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1155","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.05706-11","article-title":"The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates","volume":"56","author":"Holmes","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1160","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.02067-12","article-title":"Azole affinity of sterol 14alpha-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens","volume":"57","author":"Warrilow","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbapap.2019.02.008_bb1165","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1021\/acschembio.7b00339","article-title":"Real-time imaging of the azole class of antifungal drugs in live Candida cells","volume":"12","author":"Benhamou","year":"2017","journal-title":"ACS Chem Biol"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963919300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963919300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:21:43Z","timestamp":1778822503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963919300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":233,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1570963919300445"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2019.02.008","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fungal Lanosterol 14\u03b1-demethylase: A target for next-generation antifungal design","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"140206"}}